8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with galanin (1-15) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguirre, JA; Diaz, Z; Fuxe, K; González-Barón, S; Hedlund, PB; Narváez, JA; Yanaihara, N | 1 |
| Borroto-Escuela, DO; Díaz-Cabiale, Z; Flores-Burgess, A; Fuxe, K; Gago, B; Millón, C; Narváez, JA; Narváez, M; Santín, L | 1 |
2 other study(ies) available for 8-hydroxy-2-(di-n-propylamino)tetralin and galanin (1-15)
| Article | Year |
|---|---|
Intracisternally injected galanin-(1-15) modulates the cardiovascular responses of galanin-(1-29) and the 5-HT1A receptor agonist 8-OH-DPAT.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Blood Pressure; Cisterna Magna; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Galanin; Heart Rate; Male; Neuropeptides; Peptide Fragments; Peptides; Rats; Rats, Sprague-Dawley; Respiration | 1994 |
Galanin (1-15) enhances the antidepressant effects of the 5-HT1A receptor agonist 8-OH-DPAT: involvement of the raphe-hippocampal 5-HT neuron system.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Behavior, Animal; Dorsal Raphe Nucleus; Galanin; Hippocampus; Male; Peptide Fragments; Peptides; Rats; Rats, Sprague-Dawley; Receptor, Galanin, Type 1; Receptor, Galanin, Type 2; RNA, Messenger; Serotonergic Neurons; Serotonin Receptor Agonists | 2016 |